BSX
Boston Scientific Corporation · $46.73 (+1.6%) · mkt cap $69.5B · P/E 18.9
66 hub catalysts across 9 sources · backtest → · ← Ticker Explorer
Analyst Ratings (Upgrades/Downgrades)FINRA Short VolumeU.S. House — Congressional TradesInsider Transactions (SEC Form 4)Financial News (Google News)FDA Approvals & RecallsSEC EDGAR FilingsU.S. Senate — Congressional TradesStockTwits Social Sentiment
Signal summary
Signals divergeBullish and bearish forces are in conflict here — weigh both columns.
100▲ Bull-leanconviction from hub signals
Bullish factors
- Congress bought (5)
- FDA approval
- StockTwits 92% bullish
Bearish factors
- Congress sold (2)
- 3 analyst downgrades
- Insiders net selling (12 vs 4)
Context (not directional): Short volume 1% of float-traded · News flow (25 recent)
Signal mix for BSX
Which data feeds have fired on this name — hover a slice for counts.
Best strategy
2-yr backtest · by SharpeMomentum (rate-of-change) has fit BSX best over 2 years (+95.4%, Sharpe 1.30). Historical/in-sample — walk-forward all 19 →
| # | Strategy | Return | Sharpe | Beats B&H |
|---|---|---|---|---|
| 1 | Momentum (rate-of-change) | +95.4% | 1.30 | ✓ |
| 2 | Golden / Death Cross (50/200) | +69.4% | 1.14 | ✓ |
| 3 | Absolute Momentum (12mo) | +67.1% | 1.14 | ✓ |
Price — 1 year
daily closeInsider activity
4 open-market buysOfficers & directors trading their own stock (SEC Form 4). Buys are bullish; sells shown for context.
| Date | Action | Insider | Shares | Value |
|---|---|---|---|---|
| 2026-05-20 | BUY | Ludwig Edward J. | 3,580 | $203K |
| 2026-05-20 | BUY | Habiger David C | 4,450 | $251K |
| 2026-05-20 | BUY | Pegus Cheryl | 1,770 | $100K |
| 2026-02-02 | SELL | Mahoney Michael F | 160,901 | $15.0M |
| 2025-12-01 | SELL | Butcher Arthur C | 17,313 | $1.8M |
| 2025-11-06 | SELL | Zane Ellen M | 12,891 | $1.3M |
| 2025-11-03 | SELL | Fitzgerald Joseph Michael | 50,000 | $5.0M |
| 2025-10-28 | SELL | Zane Ellen M | 12,891 | $1.3M |
| 2025-10-01 | SELL | Fitzgerald Joseph Michael | 50,000 | $4.9M |
| 2025-09-02 | SELL | Fitzgerald Joseph Michael | 50,000 | $5.3M |
| 2025-08-01 | SELL | Fitzgerald Joseph Michael | 50,000 | $5.2M |
| 2025-08-01 | SELL | Butcher Arthur C | 17,313 | $1.8M |
| 2025-07-29 | SELL | Fujimori Yoshiaki | 2,901 | $310K |
| 2025-07-25 | SELL | Ludwig Edward J. | 4,000 | $424K |
| 2025-07-01 | SELL | Fitzgerald Joseph Michael | 50,000 | $5.3M |
| 2024-12-03 | BUY | Fitzgerald Joseph Michael | 50 | $5K |
Analyst ratings
live · 3 changes| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| 2026-07-31 | Downgrade | Argus Research | Buy → Hold |
| 2026-05-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2026-05-28 | Downgrade | Wells Fargo | Overweight → Equal-Weight |
Catalyst timeline
66 hub signals| Date | Source | Event | Entity | Value | |
|---|---|---|---|---|---|
| 2026-07-31 | Financial News (Google News) | News | Boston Scientific (BSX) Stock Ignores Margin Strength As Growth Outlook Softens - simplywall.st | 19 | source ↗ |
| 2026-07-30 | Financial News (Google News) | News | Boston Scientific (BSX) Stock Sees Modest Fair Value Cut As Watchman Concerns Reset Expectations - Yahoo! Finance Canada | 17 | source ↗ |
| 2026-07-29 | StockTwits Social Sentiment | Social Buzz | Boston Scientific Corp. | 92% bull | source ↗ |
| 2026-07-29 | SEC EDGAR Filings | 8-K Event | BOSTON SCIENTIFIC CORP | source ↗ | |
| 2026-07-28 | Financial News (Google News) | News | What To Expect From Boston Scientific’s (BSX) Q2 Earnings - Yahoo Finance | 8 | source ↗ |
| 2026-07-28 | Financial News (Google News) | News | What To Expect From Boston Scientific’s (BSX) Q2 Earnings - Yahoo Finance | 16 | source ↗ |
| 2026-07-28 | StockTwits Social Sentiment | Social Buzz | Boston Scientific Corp. | 100% bull | source ↗ |
| 2026-07-27 | FDA Approvals & Recalls | FDA Approval | FDA approved EMBLEM S-ICD Electrode (Lead) Model 3501 — Boston Scientific Corporation | approval | source ↗ |
| 2026-07-27 | SEC EDGAR Filings | 8-K Event | BOSTON SCIENTIFIC CORP | source ↗ | |
| 2026-07-23 | Financial News (Google News) | News | Why Did BSX Cut FY26 Guidance? CEO Details Three Unanticipated Factors At Bernstein Conference - Stocktwits | 15 | source ↗ |
| 2026-07-23 | Financial News (Google News) | News | Why Did BSX Cut FY26 Guidance? CEO Details Three Unanticipated Factors At Bernstein Conference - Stocktwits | 10 | source ↗ |
| 2026-07-22 | FINRA Short Volume | Short Vol | BSX | 51% short | source ↗ |
| 2026-07-22 | Financial News (Google News) | News | Boston Scientific (BSX) Stock Still Looks Undervalued Following Its 58% Slump - Yahoo Finance | 9 | source ↗ |
| 2026-07-22 | FDA Approvals & Recalls | FDA Approval | FDA approved LATITUDE NXT Remote Patient Management System; LATITUDE NX — Boston Scientific | approval | source ↗ |
| 2026-07-22 | FDA Approvals & Recalls | FDA Approval | FDA approved ADVANTIO, INGENIO, VITALIO, FORMIO, ESSENTIO, ACCOLADE, PROP — Boston Scientific Corp | approval | source ↗ |
| 2026-07-22 | FDA Approvals & Recalls | FDA Approval | FDA approved TELIGEN, ENERGEN, PUNCTUA, INCEPTA, ORIGEN, INOGEN, DYNAGEN, — Boston Scientific | approval | source ↗ |
| 2026-07-22 | FDA Approvals & Recalls | FDA Approval | FDA approved INGENIO MRI, VITALIO MRI, FORMIO MRI, ESSENTIO MRI, PROPONEN — Boston Scientific | approval | source ↗ |
| 2026-07-22 | FDA Approvals & Recalls | FDA Approval | FDA approved COGNIS, ENERGEN, PUNCTUA, INCEPTA, ORIGEN, INOGEN, DYNAGEN, — Boston Scientific Corp | approval | source ↗ |
| 2026-07-22 | FDA Approvals & Recalls | FDA Approval | FDA approved EMBLEM S-ICD — Boston Scientific Corporation | approval | source ↗ |
| 2026-07-21 | Financial News (Google News) | News | Boston Scientific (BSX) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance | 8 | source ↗ |
| 2026-07-20 | Financial News (Google News) | News | Why Did BSX Cut FY26 Guidance? CEO Details Three Unanticipated Factors At Bernstein Conference - Stocktwits | 3 | source ↗ |
| 2026-07-15 | Financial News (Google News) | News | Why Did BSX, LI, BJ Stocks Hit 52-Week Lows Today? - Stocktwits | 11 | source ↗ |
| 2026-07-15 | Financial News (Google News) | News | Why Did BSX, LI, BJ Stocks Hit 52-Week Lows Today? - Stocktwits | 8 | source ↗ |
| 2026-07-14 | Financial News (Google News) | News | Why Did BSX Cut FY26 Guidance? CEO Details Three Unanticipated Factors At Bernstein Conference - Stocktwits | 6 | source ↗ |
| 2026-06-30 | Financial News (Google News) | News | Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance | 11 | source ↗ |
| 2026-06-30 | Financial News (Google News) | News | Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance | 5 | source ↗ |
| 2026-06-30 | Financial News (Google News) | News | Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance | 3 | source ↗ |
| 2026-06-15 | FDA Approvals & Recalls | FDA Approval | FDA approved Deep Brain Stimulation (DBS) Systems — Boston Scientific Corp | approval | source ↗ |
| 2026-06-15 | FDA Approvals & Recalls | FDA Approval | FDA approved Spinal Cord Stimulation (SCS) — Boston Scientific Corp | approval | source ↗ |
| 2026-06-15 | FDA Approvals & Recalls | FDA Approval | FDA approved POLARx and POLARx Cryoablation Balloon Catheters; POLARSHEAT — Boston Scientific Corporation | approval | source ↗ |
| 2026-06-14 | Financial News (Google News) | News | Why Did BSX, LI, BJ Stocks Hit 52-Week Lows Today? - Stocktwits | 5 | source ↗ |
| 2026-06-10 | Financial News (Google News) | News | Boston Scientific (BSX) Stock Moves -1.27%: What You Should Know - Yahoo Finance | 8 | source ↗ |
| 2026-06-10 | Financial News (Google News) | News | Boston Scientific (BSX) Stock Moves -1.27%: What You Should Know - Yahoo Finance | 9 | source ↗ |
| 2026-06-10 | Financial News (Google News) | News | Boston Scientific Stock (BSX) Opinions on Recent Stock Decline - Quiver Quantitative | 6 | source ↗ |
| 2026-06-10 | Financial News (Google News) | News | Boston Scientific (BSX) Stock Moves -1.27%: What You Should Know - Yahoo Finance | 7 | source ↗ |
| 2026-06-09 | Financial News (Google News) | News | Why Did BSX, LI, BJ Stocks Hit 52-Week Lows Today? - Stocktwits | 5 | source ↗ |
| 2026-06-08 | FDA Approvals & Recalls | FDA Approval | FDA approved AMS 700 Inflatable Penile Prosthesis (IPP) with and without — Boston Scientific Corp | approval | source ↗ |
| 2026-06-08 | FDA Approvals & Recalls | FDA Approval | FDA approved WATCHMAN FLX Left Atrial Appendage Closure Device with Deli — Boston Scientific Corp | approval | source ↗ |
| 2026-06-08 | FDA Approvals & Recalls | FDA Approval | FDA approved Celestia Implantable Pulse Generator, Celestia External Tria — Boston Scientific Corp | approval | source ↗ |
| 2026-06-05 | U.S. House — Congressional Trades | Congress BUY | Hon. Gilbert Cisneros | $1,001 - $15,000 | source ↗ |
| 2026-06-05 | U.S. House — Congressional Trades | Congress SELL | Hon. Gilbert Cisneros | $1,001 - $15,000 | source ↗ |
| 2026-06-04 | U.S. Senate — Congressional Trades | Congress SELL | Boozman, John (Senator) | $1,001 - $15,000 | source ↗ |
| 2026-05-29 | U.S. House — Congressional Trades | Congress BUY | Hon. Gilbert Cisneros | $1,001 - $15,000 | source ↗ |
| 2026-05-29 | Analyst Ratings (Upgrades/Downgrades) | Analyst Downgrade | Wolfe Research: Downgrade (Outperform → Peer Perform) | source ↗ | |
| 2026-05-28 | Financial News (Google News) | News | BSX Stock: Don’t Try To Catch The Falling Knife - Trefis | 4 | source ↗ |
| 2026-05-28 | Analyst Ratings (Upgrades/Downgrades) | Analyst Downgrade | Wells Fargo: Downgrade (Overweight → Equal-Weight) | source ↗ | |
| 2026-05-28 | Financial News (Google News) | News | BSX Stock: Don’t Try To Catch The Falling Knife - Trefis | 2 | source ↗ |
| 2026-05-28 | Financial News (Google News) | News | BSX Stock: Don’t Try To Catch The Falling Knife - Trefis | 4 | source ↗ |
| 2026-05-28 | Financial News (Google News) | News | BSX Stock: Don’t Try To Catch The Falling Knife - Trefis | 4 | source ↗ |
| 2026-05-20 | Insider Transactions (SEC Form 4) | Insider BUY | Habiger David C bought 4,450 sh | $251K | source ↗ |
| 2026-05-20 | Insider Transactions (SEC Form 4) | Insider BUY | Pegus Cheryl bought 1,770 sh | $100K | source ↗ |
| 2026-05-20 | Insider Transactions (SEC Form 4) | Insider BUY | Ludwig Edward J. bought 3,580 sh | $203K | source ↗ |
| 2026-05-19 | U.S. House — Congressional Trades | Congress BUY | Hon. Gilbert Cisneros | $1,001 - $15,000 | source ↗ |
| 2026-05-11 | U.S. House — Congressional Trades | Congress BUY | Hon. Gilbert Cisneros | $1,001 - $15,000 | source ↗ |
| 2026-03-30 | Analyst Ratings (Upgrades/Downgrades) | Analyst Downgrade | Raymond James: Downgrade (Strong Buy → Outperform) | source ↗ | |
| 2026-03-27 | U.S. Senate — Congressional Trades | Congress BUY | Armstrong, Alan (Senator) | $1,001 - $15,000 | source ↗ |
| 2026-02-02 | Insider Transactions (SEC Form 4) | Insider SELL | Mahoney Michael F sold 160,901 sh | $15.0M | source ↗ |
| 2025-12-01 | Insider Transactions (SEC Form 4) | Insider SELL | Butcher Arthur C sold 17,313 sh | $1.8M | source ↗ |
| 2025-11-06 | Insider Transactions (SEC Form 4) | Insider SELL | Zane Ellen M sold 12,891 sh | $1.3M | source ↗ |
| 2025-11-03 | Insider Transactions (SEC Form 4) | Insider SELL | Fitzgerald Joseph Michael sold 50,000 sh | $5.0M | source ↗ |
| 2025-10-28 | Insider Transactions (SEC Form 4) | Insider SELL | Zane Ellen M sold 12,891 sh | $1.3M | source ↗ |
| 2025-10-01 | Insider Transactions (SEC Form 4) | Insider SELL | Fitzgerald Joseph Michael sold 50,000 sh | $4.9M | source ↗ |
| 2025-09-02 | Insider Transactions (SEC Form 4) | Insider SELL | Fitzgerald Joseph Michael sold 50,000 sh | $5.3M | source ↗ |
| 2025-08-01 | Insider Transactions (SEC Form 4) | Insider SELL | Butcher Arthur C sold 17,313 sh | $1.8M | source ↗ |
| 2025-08-01 | Insider Transactions (SEC Form 4) | Insider SELL | Fitzgerald Joseph Michael sold 50,000 sh | $5.2M | source ↗ |
| 2024-12-03 | Insider Transactions (SEC Form 4) | Insider BUY | Fitzgerald Joseph Michael bought 50 sh | $5K | source ↗ |
Alt-Data Signal Hub · collected signals updated 2026-07-31 09:16 UTC (refreshed daily) · market & option prices are always live on load · display-only, not advice